Neoadjuvant Sintilimab and Apatinib Combined with Perioperative FLOT Chemotherapy for Locally Advanced Gastric Cancer: A Prospective, Single-arm, Phase II Study
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Lin J, Tang Y, Zheng H, Ye K, Cai J, Cai L
. Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial. Nat Commun. 2024; 15(1):41.
PMC: 10762218.
DOI: 10.1038/s41467-023-44309-5.
View
2.
Huang N, Liu Y, Fang Y, Zheng S, Wu J, Wang M
. Gold Nanoparticles Induce Tumor Vessel Normalization and Impair Metastasis by Inhibiting Endothelial Smad2/3 Signaling. ACS Nano. 2020; 14(7):7940-7958.
DOI: 10.1021/acsnano.9b08460.
View
3.
Al-Batran S, Hofheinz R, Pauligk C, Kopp H, Haag G, Luley K
. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma.... Lancet Oncol. 2016; 17(12):1697-1708.
DOI: 10.1016/S1470-2045(16)30531-9.
View
4.
Cheng H, Sun A, Guo Q, Zhang Y
. Efficacy and safety of apatinib combined with chemotherapy for the treatment of advanced gastric cancer in the Chinese population: a systematic review and meta-analysis. Drug Des Devel Ther. 2018; 12:2173-2183.
PMC: 6047854.
DOI: 10.2147/DDDT.S170678.
View
5.
Shitara K, Rha S, Wyrwicz L, Oshima T, Karaseva N, Osipov M
. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study. Lancet Oncol. 2023; 25(2):212-224.
DOI: 10.1016/S1470-2045(23)00541-7.
View